Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration

文献类型： 外文期刊

第一作者： Yin, Donghao

作者： Yin, Donghao;Yang, Xuemeng;Li, Quanwei;Li, Xiuhui;Wang, Xiaojun;Li, Xiang;Yang, Xuemeng;Li, Zhen;Geng, Jiahao;Xu, Yanyu;Xu, Zijing;Wang, Zixuan;Hu, Linlan;Wang, Jiabo;Song, Xinhua;Shang, Xiaofei;Li, Zhen;Shang, Zimeng;Yang, Zhiyun

作者机构：

关键词： Hepatocellular carcinoma; Huqi formula; Apoptosis; T cells; Immunotherapy

期刊名称：CHINESE MEDICINE （ 影响因子：5.7； 五年影响因子：5.7 ）

ISSN： 1749-8546

年卷期： 2025 年 20 卷 1 期

页码：

收录情况： SCI

摘要： BackgroundHepatocellular carcinoma (HCC) poses ongoing difficulties for public health systems due to its high incidence and poor prognosis. Huqi formula (HQF), a well-known prescription in traditional Chinese medicine, has demonstrated notable clinical effectiveness in the treatment of HCC. However, the mechanisms underlying its therapeutic effects have yet to be completely elucidated.PurposeThis study aimed to investigate the anti-HCC effects of HQF and its underlying mechanisms.MethodsChemical profiling and quantification of HQF were conducted by LC-MS and HPLC. Orthotopic and subcutaneous tumor models were established through hydrodynamic injection of Akt/Nras plasmids and subcutaneous injection of c-Met/sgPten cells, respectively, to evaluate the therapeutic effects of HQF on HCC. Network pharmacology, RNA-Seq, molecular docking, Western blot, and flow cytometry were employed to assess the anti-HCC mechanisms.ResultsLC-MS analysis identified 41 components, with HPLC quantification showing salvianolic acid B as the most abundant compound (0.303%). In Akt/Nras and c-Met/sgPten-induced HCC models, HQF significantly reduced tissue damage, improved liver function, and inhibited HCC progression. Mechanistic studies revealed that HQF induced apoptosis in HCC cells by downregulating p-PI3K, p-AKT, and p-mTOR expression, with molecular docking indicating the strongest binding affinity between salvianolic acid B and PI3K. HQF further enhanced CD4+ and CD8+ T cell infiltration within the tumor microenvironment. When combined with PD-1 therapy, HQF improved therapeutic efficacy against HCC. Finally, toxicity assays confirmed the safety profile of HQF.ConclusionHQF demonstrated significant anti-HCC effects and a synergistic effect with PD-1, could be used as an alternative therapeutic agent for HCC.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序